Dare Bioscience Inc (DARE)
0.4133
-0.02
(-4.02%)
USD |
NASDAQ |
May 31, 16:00
0.41
0.00 (0.00%)
After-Hours: 20:00
Dare Bioscience Research and Development Expense (Quarterly): 3.328M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.328M |
| December 31, 2023 | 3.800M |
| September 30, 2023 | 6.675M |
| June 30, 2023 | 6.044M |
| March 31, 2023 | 5.020M |
| December 31, 2022 | 12.98M |
| September 30, 2022 | 4.462M |
| June 30, 2022 | 6.798M |
| March 31, 2022 | 5.806M |
| December 31, 2021 | 7.116M |
| September 30, 2021 | 10.43M |
| June 30, 2021 | 7.340M |
| March 31, 2021 | 5.728M |
| December 31, 2020 | 6.638M |
| September 30, 2020 | 6.204M |
| June 30, 2020 | 5.548M |
| March 31, 2020 | 2.380M |
| December 31, 2019 | 2.374M |
| September 30, 2019 | 1.966M |
| June 30, 2019 | 2.513M |
| March 31, 2019 | 1.693M |
| December 31, 2018 | 1.663M |
| September 30, 2018 | 1.446M |
| Date | Value |
|---|---|
| June 30, 2018 | 2.218M |
| March 31, 2018 | 1.087M |
| December 31, 2017 | 0.6726M |
| September 30, 2017 | 0.2808M |
| June 30, 2017 | 0.0036M |
| March 31, 2017 | 0.0278M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 7.522M |
| March 31, 2016 | 9.77M |
| December 31, 2015 | 7.157M |
| September 30, 2015 | 7.092M |
| June 30, 2015 | 6.678M |
| March 31, 2015 | 5.021M |
| December 31, 2014 | 4.701M |
| September 30, 2014 | 2.928M |
| June 30, 2014 | 2.648M |
| March 31, 2014 | 1.495M |
| December 31, 2013 | 1.44M |
| September 30, 2013 | 1.586M |
| June 30, 2013 | 3.195M |
| March 31, 2013 | 3.479M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.966M
Minimum
Sep 2019
12.98M
Maximum
Dec 2022
5.657M
Average
5.767M
Median
Research and Development Expense (Quarterly) Benchmarks
| Altimmune Inc | 21.49M |
| Verastem Inc | 17.71M |
| Oragenics Inc | 0.6634M |
| Actinium Pharmaceuticals Inc | 6.635M |
| Orgenesis Inc | 2.37M |